| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9AKT2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.580 |
| CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.563 |
| CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.469 |
| CLV_PCSK_PC1ET2_1 | 96 | 98 | PF00082 | 0.469 |
| CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.650 |
| CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.536 |
| DOC_CKS1_1 | 235 | 240 | PF01111 | 0.405 |
| DOC_CYCLIN_RxL_1 | 241 | 250 | PF00134 | 0.582 |
| DOC_PP2B_LxvP_1 | 35 | 38 | PF13499 | 0.504 |
| DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.652 |
| DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.751 |
| DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.694 |
| DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.553 |
| DOC_USP7_MATH_1 | 76 | 80 | PF00917 | 0.445 |
| DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.701 |
| DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.406 |
| DOC_WW_Pin1_4 | 267 | 272 | PF00397 | 0.423 |
| DOC_WW_Pin1_4 | 40 | 45 | PF00397 | 0.649 |
| LIG_14-3-3_CanoR_1 | 160 | 169 | PF00244 | 0.635 |
| LIG_14-3-3_CanoR_1 | 173 | 179 | PF00244 | 0.438 |
| LIG_14-3-3_CanoR_1 | 290 | 295 | PF00244 | 0.628 |
| LIG_14-3-3_CanoR_1 | 83 | 91 | PF00244 | 0.588 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.647 |
| LIG_BRCT_BRCA1_1 | 165 | 169 | PF00533 | 0.411 |
| LIG_BRCT_BRCA1_1 | 2 | 6 | PF00533 | 0.571 |
| LIG_BRCT_BRCA1_1 | 292 | 296 | PF00533 | 0.633 |
| LIG_CSL_BTD_1 | 222 | 225 | PF09270 | 0.391 |
| LIG_CSL_BTD_1 | 235 | 238 | PF09270 | 0.410 |
| LIG_FHA_1 | 17 | 23 | PF00498 | 0.696 |
| LIG_FHA_1 | 172 | 178 | PF00498 | 0.563 |
| LIG_FHA_1 | 235 | 241 | PF00498 | 0.405 |
| LIG_FHA_1 | 243 | 249 | PF00498 | 0.386 |
| LIG_FHA_1 | 28 | 34 | PF00498 | 0.532 |
| LIG_FHA_2 | 268 | 274 | PF00498 | 0.262 |
| LIG_HCF-1_HBM_1 | 250 | 253 | PF13415 | 0.450 |
| LIG_LIR_Gen_1 | 250 | 260 | PF02991 | 0.367 |
| LIG_LIR_Nem_3 | 214 | 218 | PF02991 | 0.609 |
| LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.389 |
| LIG_REV1ctd_RIR_1 | 88 | 97 | PF16727 | 0.492 |
| LIG_SH2_CRK | 253 | 257 | PF00017 | 0.424 |
| LIG_SH2_NCK_1 | 69 | 73 | PF00017 | 0.450 |
| LIG_SH2_SRC | 69 | 72 | PF00017 | 0.512 |
| LIG_SH2_STAP1 | 274 | 278 | PF00017 | 0.387 |
| LIG_SH2_STAP1 | 80 | 84 | PF00017 | 0.416 |
| LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.639 |
| LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.456 |
| LIG_SH3_3 | 195 | 201 | PF00018 | 0.665 |
| LIG_SH3_3 | 41 | 47 | PF00018 | 0.643 |
| LIG_SUMO_SIM_anti_2 | 231 | 237 | PF11976 | 0.523 |
| LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.636 |
| LIG_UBA3_1 | 33 | 39 | PF00899 | 0.538 |
| MOD_CAAXbox | 294 | 297 | PF01239 | 0.652 |
| MOD_CK1_1 | 15 | 21 | PF00069 | 0.643 |
| MOD_CK1_1 | 183 | 189 | PF00069 | 0.567 |
| MOD_CK1_1 | 190 | 196 | PF00069 | 0.684 |
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.585 |
| MOD_CK1_1 | 43 | 49 | PF00069 | 0.529 |
| MOD_CK2_1 | 130 | 136 | PF00069 | 0.710 |
| MOD_CK2_1 | 140 | 146 | PF00069 | 0.649 |
| MOD_CMANNOS | 223 | 226 | PF00535 | 0.499 |
| MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.623 |
| MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.533 |
| MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.554 |
| MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.673 |
| MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.602 |
| MOD_GSK3_1 | 111 | 118 | PF00069 | 0.622 |
| MOD_GSK3_1 | 12 | 19 | PF00069 | 0.680 |
| MOD_GSK3_1 | 159 | 166 | PF00069 | 0.570 |
| MOD_GSK3_1 | 183 | 190 | PF00069 | 0.520 |
| MOD_N-GLC_1 | 12 | 17 | PF02516 | 0.747 |
| MOD_N-GLC_1 | 130 | 135 | PF02516 | 0.586 |
| MOD_NEK2_1 | 256 | 261 | PF00069 | 0.429 |
| MOD_PIKK_1 | 160 | 166 | PF00454 | 0.617 |
| MOD_PIKK_1 | 180 | 186 | PF00454 | 0.401 |
| MOD_PKA_2 | 159 | 165 | PF00069 | 0.559 |
| MOD_PKA_2 | 172 | 178 | PF00069 | 0.443 |
| MOD_PKA_2 | 256 | 262 | PF00069 | 0.392 |
| MOD_PKA_2 | 284 | 290 | PF00069 | 0.542 |
| MOD_PKB_1 | 288 | 296 | PF00069 | 0.680 |
| MOD_Plk_4 | 202 | 208 | PF00069 | 0.520 |
| MOD_Plk_4 | 211 | 217 | PF00069 | 0.495 |
| MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.696 |
| MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.405 |
| MOD_ProDKin_1 | 267 | 273 | PF00069 | 0.423 |
| MOD_ProDKin_1 | 40 | 46 | PF00069 | 0.642 |
| MOD_SUMO_for_1 | 169 | 172 | PF00179 | 0.652 |
| TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.367 |
| TRG_ER_diArg_1 | 208 | 210 | PF00400 | 0.609 |
| TRG_Pf-PMV_PEXEL_1 | 97 | 102 | PF00026 | 0.594 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I6B6 | Leptomonas seymouri | 69% | 98% |
| A0A1X0NKM4 | Trypanosomatidae | 42% | 98% |
| A0A3S7WPG5 | Leishmania donovani | 92% | 100% |
| A0A422NGX7 | Trypanosoma rangeli | 41% | 100% |
| A4H4L9 | Leishmania braziliensis | 80% | 100% |
| A4HSU5 | Leishmania infantum | 92% | 100% |
| C9ZTF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
| Q4QJ25 | Leishmania major | 89% | 100% |
| V5B7V6 | Trypanosoma cruzi | 43% | 100% |